Contact Us
Drug Search Results
More Filters [+]

Bocidelpar

Alternative Names: Bocidelpar, asp-0367, asp 0367, asp0367
Latest Update: 2024-08-30
Latest Update Note: Clinical Trial Update

Product Description

an orally administered PPAR_ modulator

Mechanisms of Action: PPAR-d Modulator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: Fast Track - Mitochondrial Myopathies *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Astellas Pharma
Company Location: NEW YORK NY 10005
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Bocidelpar

Countries in Clinic: United States

Active Clinical Trial Count: 3

Highest Development Phases

Phase 1: Acute Respiratory Distress Syndrome|Healthy Volunteers|Kidney Diseases|Mitochondrial Myopathies|Muscular Dystrophy, Duchenne

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
0367-CL-1111

P1

Completed

Kidney Diseases

2022-11-13

0367-CL-1103

P1

Completed

Muscular Dystrophy, Duchenne|Mitochondrial Myopathies|Acute Respiratory Distress Syndrome

2022-04-30

0367-CL-1102

P1

Completed

Healthy Volunteers

2022-01-11

Recent News Events

Date

Type

Title

10/20/2020

News Article

 U.S. FDA Grants Fast Track Designation for ASP0367/MA-0211, a Selective PPARδ Modulator being Developed for the Treatment of Primary Mitochondrial Myopathies

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions